Comparison of excess deaths and laboratory-confirmed COVID-19 deaths during a large Omicron epidemic in 2022 in Hong Kong

Hualei Xin, Alexandra H. T. Law, Justin Cheung, Yun Lin, Peng Wu, Zhongjie Li, Benjamin J. Cowling, Weizhong Yang, Jessica Y. WongJournal of Global Health 2025 · DOI

TL;DR

This study reveals that in 2022, Hong Kong experienced a significant increase in overall mortality (excess deaths) that slightly surpassed the number of officially recorded COVID-19 deaths. This suggests that the Omicron wave's impact on mortality may have been broader than initially captured by laboratory-confirmed cases, potentially due to indirect effects or the displacement of deaths from other causes.

What Problem Does This Paper Address?

The COVID-19 pandemic has presented a major challenge in accurately quantifying its true mortality burden. While laboratory-confirmed deaths provide a direct measure, they may underestimate the total impact due to factors like misclassification of causes of death, limited diagnostic capacity, and indirect health impacts such as disruptions to healthcare services or changes in health-seeking behaviors. "Excess mortality," defined as the difference between observed and expected deaths under normal conditions, offers a more comprehensive metric. This paper addresses the question of how well laboratory-confirmed COVID-19 deaths reflect the true mortality impact during a large Omicron wave in Hong Kong, a region that previously employed an elimination strategy.

Methods

The researchers employed a negative binomial regression model to estimate weekly all-cause and cause-specific mortality from 2010 to 2021, projecting counterfactual baselines for 2022 in the absence of the pandemic. By comparing these projected baselines with the observed weekly deaths in 2022, they calculated excess mortality. This excess mortality was then compared with the number of laboratory-confirmed COVID-19 deaths, analyzed across different age groups, sexes, and epidemic periods. The study also examined cause-specific excess mortality, focusing on respiratory, cardiovascular, and malignant neoplasms, among others.

Datasets

The study utilized individual death data from the Census and Statistics Department of Hong Kong from 2010 to 2022. Weekly mortality data were aggregated by age, sex, and cause of death, coded according to the International Classification of Diseases Tenth Revision (ICD-10). Data on individual patients with laboratory-confirmed SARS-CoV-2 in 2022 were obtained from the Hong Kong Hospital Authority, Centre for Health Protection, and the Deaths Registry. Annual mid-year population data by age and sex were also used.

Key Insights and Ideas

  • Excess Mortality as a Broader Indicator: The study underscores the value of excess mortality as a metric that captures the full spectrum of a pandemic's impact, including direct and indirect effects, which laboratory-confirmed deaths alone might miss.
  • Omicron's Significant Impact: Despite Hong Kong's prior success with an elimination strategy, the Omicron wave in 2022 led to a substantial increase in overall mortality, highlighting the variant's transmissibility and potential to overwhelm even well-prepared systems.
  • Potential for Mortality Displacement: The finding that excess deaths slightly exceeded confirmed COVID-19 deaths, particularly in older adults, raises the possibility of "mortality displacement," where COVID-19 may have hastened the deaths of individuals already near the end of life from other causes.
  • Age and Sex Disparities: Older adults (≥80 years) bore the brunt of both excess mortality and confirmed COVID-19 deaths, with males generally experiencing higher excess mortality than females across most age groups.
  • Cause-Specific Shifts: While respiratory diseases accounted for the largest proportion of excess deaths, a notable finding was a slight reduction in mortality from malignant neoplasms, potentially linked to changes in healthcare seeking or treatment during the pandemic.

Key Results

  • An estimated 13,518 excess deaths (184 per 100,000 population) occurred in Hong Kong in 2022, representing a 27% increase in all-cause mortality compared to the predicted baseline.
  • This figure was slightly higher than the 12,228 laboratory-confirmed COVID-19 deaths recorded in the same year.
  • The largest difference between excess deaths and confirmed COVID-19 deaths was observed during the peak of the Omicron BA.2 wave (February-April 2022), with an estimated 847 more excess deaths.
  • Respiratory diseases were the leading cause of excess deaths (78%), followed by cardiovascular causes (10%).
  • Individuals aged 80 years and above experienced the highest excess mortality risk.

Limitations and Future Work

The authors acknowledge several limitations:

  • Difficulty in Separating Direct vs. Indirect Impact: The study could not definitively separate the direct impact of COVID-19 infection from indirect impacts (e.g., healthcare system strain, behavioral changes). Future research could explore methods to disentangle these effects.
  • Small Group Sizes: The accuracy of excess mortality estimates for smaller demographic groups, such as children aged 5-14, may be limited due to small weekly death counts.
  • Baseline Period: Using the first two years of the pandemic (2020-2021) as part of the baseline, rather than solely pre-pandemic data, might lead to slight under- or overestimation if structural changes in health systems or population health outcomes occurred during those years. However, the model did account for potential changes in the mortality trend since January 2020.

Future work could focus on developing more robust methods to differentiate direct and indirect mortality impacts and refining estimates for smaller population subgroups. The study also highlights the importance of effective pharmaceutical interventions, particularly vaccines, in mitigating the overall health burden of pandemics, especially for vulnerable populations.

Summary updated

Abstract

A substantial increase in population mortality was identified in 2022 in Hong Kong, slightly larger than the laboratory-confirmed COVID-19 deaths. Deaths from COVID-19 may have displaced some deaths that would otherwise have occurred due to other causes.
BibTeX
@article{xin2025comparison,
  author = {Hualei Xin and Alexandra H. T. Law and Justin Cheung and Yun Lin and Peng Wu and Zhongjie Li and Benjamin J. Cowling and Weizhong Yang and Jessica Y. Wong},
  title = {{Comparison of excess deaths and laboratory-confirmed COVID-19 deaths during a large Omicron epidemic in 2022 in Hong Kong}},
  journal = {Journal of Global Health},
  year = {2025},
  doi = {10.7189/jogh.15.04105},
}
Figure